Transplant outcomes of the entire cohort and according to the number of donor-related risk factors
| Outcome∗ . | Overall % (95% CI) . |
|---|---|
| Acute GVHD | |
| Grade 2-4 | 28 (26-30) |
| Grade 3-4 | 11 (10-12) |
| Chronic GVHD | |
| Overall | 33 (31-35) |
| Extensive | 14 (12-15) |
| NRM | 22 (20-24) |
| RI | 26 (24-28) |
| LFS | 52 (50-55) |
| OS | 57 (55-60) |
| GRFS | 41 (39-43) |
| Outcome∗ . | Overall % (95% CI) . |
|---|---|
| Acute GVHD | |
| Grade 2-4 | 28 (26-30) |
| Grade 3-4 | 11 (10-12) |
| Chronic GVHD | |
| Overall | 33 (31-35) |
| Extensive | 14 (12-15) |
| NRM | 22 (20-24) |
| RI | 26 (24-28) |
| LFS | 52 (50-55) |
| OS | 57 (55-60) |
| GRFS | 41 (39-43) |
RI, relapse incidence.
Acute GVHD: 180-day cumulative incidence; cGvHD, NRM, and RI: cumulative incidence at 2 years; LFS, OS, and GRFS: survival probability at 2 years.